section. The authors of the current paper should explore and describe the degree to which BCG vaccination is delayed in or withheld from severely ill young neonates in the study area and over the relevant time period. The statement "Nonetheless, the effect size was similar to that observed in other studies where BCG reduced neonatal mortality" gives the impression that BCG reduces neonatal mortality. We advise the authors to use more cautious language in that such causality would require adequately powered and well executed randomized controlled trials (RCTs), which to our knowledge are few and far between. It could be worthwhile in the Discussion section to mention that WHO's Strategic Advisory Group of Experts (SAGE) [to which the authors adequately refers elsewhere) established a working group on non-specific effects of vaccines, including of BCG, and that its Immunization and vaccines related implementation research advisory committee (IVIR-AC) concludes that RCTs are indeed required to resolve the question of whether BCG has non-specific beneficial effects on infant survival (http://www.who.int/immunization/research/implementation/nse_pro tocol_comments/en). The Discussion section could also point to the recent call for public comments on draft protocols of clinical trials to assess any non-specific effects of vaccines (http://www.who.int/immunization/research/implementation/nse_pro tocol_comments/en, including of BCG (http://www.who.int/entity/immunization/research/implementation/S ynopsis_BCG_Study_protocol _2_April_17.pdf?ua=1). There are several statements which require the use of more cautious language. Two examples: Please consider exchanging:
1.
"The findings of this research in the aggregated level are in agreement with other recent studies with individual-level designs, showing a beneficial effect of early BCG vaccination on neonatal mortality.» with «The findings of this research in the aggregated level are in agreement with other recent studies with individuallevel designs, which indicates that there may be a beneficial effect of early BCG vaccination on neonatal mortality.» (The authors use adequately and admirably cautious language when referring to the two RCTs among low-birth weight neonates in Guinea-Bissau). 2.
«However, there are several reasons why the results suggest that the decline in mortality rates over the period is causally linked to the decline in BCG vaccination age» with «However, there are several reasons why the results suggest that the decline in mortality rates over the period may be associated with the decline in BCG vaccination age»
The ecological nature of the analyses warrants an explicit discussion on what other factors may be at work for the declining neonatal mortality, this includes a vast array of changes from demographic (fewer children per household), diagnostic (reduced misclassification between stillbirths and day1 deaths), nutritionalmedical (availability of better obstetric care, better coverage of vaccines other than BCG, better availability of appropriate treatment of newborn illnesses, better access to nutritious food), socio-economic (maternal education, employment, income) etc.
In accordance with the above arguments, we believe the paper's conclusion should be better aligned with that of the WHO, that RCTs are required to address the question of whether there indeed is a causal association between early BCG vaccination and neonatal survival.
To the specific text and data analysis etc.:
Abstract: Rephrase the Objective to: «To assess the non-specific effects of early BCG vaccination on neonatal mortality in Northern Ghana» so it becomes that of an objective and not a statement of what was done.
The rest of the abstract should be modified to reflect the revision of the rest of the manuscript as a response to the independent reviews.
It is stated that ''In a small subgroup of children whose vaccination cards were inspected within the first 28 days of life, early BCGvaccination tended to be associated with 47% lower neonatal mortality (HR=0.53(95%CI=0.12-2.35)).'' However, the estimate in reported here is statistically very imprecise (the upper to lower confidence ratio is actually as large as 19.6) and even though the authors use of the word 'tended', thestatement is inappropriate.
Introduction: "The Expanded Programme on Immunization (EPI) in Ghana recommends that BCG be given at birth." This begs a reference, all the more so that this (good) recommendation is more proactive than that of the WHO, which recommends that BCG be given as soon as possible after birth.
The sentence "Immunological studies have recently showed that BCG vaccines can train the innate immune system via epigenetic modifications at the monocyte level, and thus provided a mechanism whereby early BCG administration can modulate a child's ability to combat concurrent or subsequent unrelated infections" needs a minor change of the grammar (showed>shown). More importantly, considering the experimental design of the quoted study (adults and mice) and the danger of extrapolating (also to neonates) necessitates, again, more cautious language.
Materials and methods:
Please briefly explain what the Landmark approach is and how it reduces the tendency of survival bias. The regression model used in the individual level analysis should be described, we assume it is a Cox regression model, but that is, as far as we can see, not stated anywhere.
What was the proportion of children (both dead and alive) with missing vaccination cards, especially before 2011 when data was collected annually? This is important to know because all children without cards were classified as not having been vaccinated, in itself an assumption which warrants some scrutiny. Furthermore, the authors state that this under-reporting of vaccination would result in a conservative estimate, which would imply that a bias resulting from this cannot fully explain their finding. This may be true for scenario 1 described below but not for scenario 2
1)
Scenario 1: Under-reporting of vaccination among children who are still alive but with no vaccination cards would mean that some children who were alive and vaccinated would be erroneously misclassified as alive but unvaccinated. This would result in a conservative error/underestimation, i.e. that BCG would seem to be less protective against death than it should be, i.e. as reported by the authors.
2)
Scenario 2: Among many of the dead children, vaccination cards are likely to have been thrown away. This would not affect the total number reported of dead unvaccinated children but it would reduce the total number of reported dead and vaccinated children who would be misclassified as dead and unvaccinated. A scenario such as this would not lead to a conservative error. In fact, it would result in overestimation of the protective effect of the vaccine. Of the two scenarios, the second one is likely to yield the most pronounced bias because of the numbers (loss from a small cell of those vaccinated and dead and gain in a relatively small unstable cell of those unvaccinated and dead [scenario 2] vs. loss from a large stable cell of vaccinated and alive and gain in a large and stable cell of unvaccinated and alive children [scenario 1]) and the overall effect is possibly overestimation not underestimation of the protective effect of the vaccine. In fact, the authors should clarify whether they included all deaths irrespective of whether they had missing vaccination cards. This will bring the reader closer to an understanding of which biases may be at work.
In sum, it is not possible to predict the direction of the bias as the authors seem to do, but if one feels compelled to take a stand, the direction of the bias in our mind would be opposite to that stated by the authors.
1)
Generally, more details should be provided in the methods section, e.g.: Was there any loss to follow-up e.g., births in the study area that had no outcome data perhaps because of migration? If yes, what was the proportion and how was it addressed? 2) Any efforts to assess and account for any potential confounding. As stated elsewhere, confounder control even in the individual level analysis seems inadequate.
3)
How were the very early neonatal deaths assessed and distinguished from intrapartum stillbirths among births occurring at home where faint traces of life at birth may be difficult to identify? 4) Which a priori sample size estimations were done for the individual level sub-study? Given that the estimate from this study was statistically very imprecise (and far from statistically significant using any commonly used cutoff), a post-hoc power calculation could be helpful 5)
For the individual data analysis: The exposure data (vaccination) does not seem to have been collected before occurrence of the outcome for all participants? If not, what are the possible resultant implications 6)
How was the wealth index variable measured and constructed?
Results: The paper presents an ecological association between lowering of vaccination age and declining neonatal mortality. Before concluding that it is indeed the declining age of vaccination per se which is somehow associated with lower early neonatal (<1 week) and overall neonatal mortality or whether it is the coverage during the early neonatal (where mortality is greater than later in the neonatal period) which is the driver for this statistical association, there is a need to present the total BCG coverage on the day of birth (day 1), of 2-7 old infants (where early neonatal deaths occur) and of the older neonates. Further, the total overage in the entire neonatal period should be presented. Thus, if the coverage in the neonatal period overall is similar, it may indeed be the lower age at which BCG is given (thereby protecting babies when they have a higher mortality) which drives the association. On the other hand, if overall BCG coverage in the neonatal period increases as the years go by, this may be the driver of the statistical association. In fact, both of these components may contribute to the association. We do appreciate the simple and numeric way Table 1 attempts to present data but ask the authors to present them with no overlap between relevant periods so that the following becomes evident: Proportion BCG vaccinated on day 1 (day 0 is a misnomer), MR day 1, Proportion BCG vaccinated days 2-7, MR days 2-7, Proportion BCG vaccinated days 8-28 and MR days 8-28. The reader will then be able to better assess whether this statistical association is one of coverage in each of these neonatal periods and/or of overall BCG coverage in the neonates, or both. Even if it should turn out that there are similarly strong (negative) associations between coverage and neonatal mortality and if other data could rule out the confounders that may be inherent to ecological studies ("ecological fallacy", please see above), this will in fact not weaken the argument that BCG may have non-specific beneficial effects on early neonatal and overall neonatal survival but it would disentangle timing per se from coverage.
Decline in NMR among home and health facility deliveries: The authors report that decline in NMR was faster among home deliveries than health facilities and by 2012, mortality at both options was the same at 13/1000. Are there any explanations for NMR among births without access to emergency obstetric care being similar to that among births with some degree of access?
BCG vaccination status and subsequent neonatal mortality: This should not be described as a sub-group because it is not a subgroup of the ecological study [where there would have been (an)other subgroup(s)]. Better to describe this as a sub-study or distinct study with individual level data. More importantly, there are several other factors than those included in the Cox regression model one would want to adjust for in such an individual level analyses. Other observational studies of the association between child mortality and vaccines can be used as a guide to how such adjustments could be made. In short, confounding which could be adjusted for if taking other potential confounders into account must be done. We are not of the opinion that a small study which will yield statistically imprecise estimates is of no value, but the authors must proceed beyond adjusting for maternal education, sex of the children and wealth. Although we are aware that also an analysis of effect measure modification will be underpowered, given some of the authors' interest in assessing whether sex is an effect modifier for any non-specific effects of vaccines, it would seem logical to explore whether the HR differs between girls and boys. In fact, it is a statistically healthy approach to, prior to any adjustment, examine for interaction. This study can be improved upon by more closely following the STROBE guidelines for reporting (and thereby for the analyses) of observational epidemiological studies.
Community-based Health Planning and Services (CHPS):
This study, although interesting, seems a bit out of place. The statistical comparison of the different cells ("decline in NMR appeared stronger in the intervention communities compared to the nonintervention communities (slope: -2.48 for intervention and -0.77 for non-intervention, p=0.11)" would require a more explicit description of this study, was it a cluster-randomized trial, a natural experiment, how many clusters, how was any design effect adjusted for etc.? Probably best to restrict the presentation of this study, if it should at all be included, to relate to BCG timeliness and coverage.
Discussion: It is stated that the individual-level study provided a conservative estimate, i.e. that the HR is actually even lower than what is depicted. That is wrong; given the "limited quality" (quote from Discussion) and lack of appropriate confounder control (see above), under-reporting of vaccination with potential resultant bias and absence of an attempt to address the issue of reverse causality (see above), as well as the statistically imprecise estimate, it is impossible to say whether the HR point estimate is conservative, correct or exaggerated, one can just say that it's not possible to know whether it is valid.
Interpretation: For the many reasons mentioned above, we commend the authors for up front stating that "The parallel decline in mortality rates and BCG vaccination age could be a coincidence". Although the authors further down do write that "Our results should be interpreted with caution…" and while we think that the first three points of the interpretation have some valid arguments, they should be presented with more caution and the fourth point corrected as suggested above.
Kampala and Bergen 23rd of October, 2017
Victoria Nankabirwa (sign.) and Halvor Sommerfelt (sign.)
REVIEWER

Danielle Ehret
University of Vermont, Larner College of Medicine, Burlington, VT, USA REVIEW RETURNED 22-Nov-2017
GENERAL COMMENTS
The research question is interesting, and the authors have used locally collected and available data to investigate the evidence of an association between timing of BCG vaccination and neonatal mortality rates.
In general, the description of the neonatal mortality rate and BCG vaccination rates and timing of vaccination was adequate. However, the methods for the statistical testing of an association of these two variables over time was incomplete. A test of this association in the overall cohort, in addition to the subgroup based on place of delivery would be worthwhile if this information is known.
If available, demographic information on the infants and mothers in a table 1 would have been interesting to review, as well as for readers to use when considering the generalizability of this work to their setting. Also, further simplifying the number and complexity of the tables would allow for the results to be displayed more clearly.
Although the health system and CHPS is mentioned in the results section, further incorporation into the discussion section is warranted. In general, the discussion does not adequately address the limitations of using a cohort to answer this question and the sources of bias. The vaccine itself may be a co-intervention within a bundle of care that is provided at birth. It may be the care, or the counseling that accompanies it that is related to the declining neonatal mortality rate. A more detailed description of care potentially bundled with BCG vaccination would clarify this limitation, as well as pertain to the generalizability. The groups vaccinated vs. unvaccinated are likely different in other regards. Although there has been some adjustment for potential confounders (SES, sex, maternal education and year) among those delivered at home, there are likely many unmeasured differences. This limitation should be mentioned. Is there information on the education of the providers of home deliveries? Is there a marker of illness severity at the time of birth (are infants not vaccinated because they already appear ill/asphyxiated and are at an elevated baseline risk of death)?
Why is BCG vaccination under-reported? Is this variable obtained through history, medical record, vaccine book?
Is there any local data to suggest that stock-outs, or availability of vaccine are an issue in facilities in this study? In the conclusion, the authors recommend that funders consider monitoring local implementation practices regarding wastage management. This is one important issue in implementation, however there may be others. An additional general sentence advising the construction of a process map or use of continuous quality improvement methodology at individual facilities may be advisable to learn about the barriers to timely implementation of BCG to all eligible infants.
Thank you for exploring this interesting question, and sharing your work.
VERSION 1 -AUTHOR RESPONSE
BMJOpen-appeal Dear Dr. Hemali Bedi, Thank you for your letter. We would like to state that we might have inappropriately stated our research objective in the abstract and used the word 'causality' and 'link' in our manuscript which could be interpreted as the study trying to establish causality using conversational data. However, this is an observation study and we can therefore only show an association as indicated by reviewer 3.
Our study is primarily an ecological study, and with all its limitations in terms of the strength of the evidence and ecological fallacy that we acknowledged in our study, we believe that the findings are useful and could help generate other hypotheses that more detailed epidemiological approaches can be used to investigate. It is unethical to conduct randomized control trials in assessing the nonspecific effects of BCG vaccines on child survival. The evidence from observational data, despite all the weaknesses, can be very useful in prompting policy makers and researchers to invest more in this area of research which has the potential to further improve child health using the already existing vaccines.
This perspective was clearly recognized by Reviewer 1 who in the first review wrote: "Lovely paper".
Please find below the comments of reviewer 2 and our responses which seek to provide some clarity to the concerns raised by reviewer 3. Reviewer 3 did not really document errors in the epidemiological analyses. He asked for clarification of why we had separate home deliveries and institutional deliveries. We have provided that explanation below. Otherwise, his dissatisfaction seems mainly to be related to the choice of words in the paper. Both reviewers acknowledged that the subject is important.
With that background in mind, we would therefore ask you to reconsider BMJ Open's decision.
Reviewer 2 "The objective in the abstract is " of early BCG vaccination on neonatal mortality in Northern Ghana". The title is misleading by including the word "causality". It is impossible to determine causality in this type of research study. Even the word "linked" may be interpreted as causality. This study will only show an association, and the authors should be more careful to not overstate their findings."
Response
We may have inappropriately stated our research objective in the abstract and used the word 'causality' in our title. However, this is an observation study and we can therefore only show an association as indicated by reviewer 3. We have revised our objective in the abstract to read as "To examine the association between early BCG vaccination and neonatal mortality in Northern Ghana". We have also revised the title to read as "Is the decline in neonatal mortality in Northern Ghana, 1996-2012, associated with the decline in the age of BCG vaccination? An observational study" To reduce the risk of overstating our findings, the statement "To assess whether early BCG vaccination could be linked to reductions in neonatal mortality" in the last paragraph of the introduction has also been revised to read as "To assess whether early BCG vaccination could be associated with a decrease in neonatal mortality…"
Reviewer2
There is a typo or missing information in the abstract, third sentence. neonatal mortality declined "with" 24/1000. The author could say declined from __ to __, or declined "by" __/1000 live births. Response This has been corrected. The word 'with' has been replaced with 'by'
The first sentence of the abstract's conclusion is too strongly worded to imply causality. The word "reduce" is better replaced with "may be associated with a decrease in".
Response
The word 'reduce' has been replaced with 'may be associated with a decrease in'
Reviewer3
It is unclear why infants delivered in health facilities and vaccinated would be excluded from this study. Also, in the methods, it becomes clear that the authors are looking at death between the interval from first home visit and 28 days. However, it is not defined the time period in which these home visits occur.
Response
We did not exclude children delivered in health facilities from the population level analysis. We excluded neonates delivered in health facilities in the sub-study involving individual level analysis due to a number of reasons. First, we did not have complete data on delivery place for the entire period of the study. Data on place of delivery was only available from 2002. Second, the background characteristics including access to healthcare of the children delivered in health facilities, which we could not measure in this study, may be different from those delivered at home. We therefore limited the analysis to home deliveries which are likely to have the same background characteristics including health seeking behaviour and access to healthcare.
To reduce the risk of introducing survival bias, all the children who were alive were first visited to assess their BCG vaccination status. We then assessed their mortality between the interval from first home visit and 28 days. We conducted 3 to 4 monthly home visits to assess survival status during the period of the study from 1996 to 2012 i.e. 3 to 4 times in a year. We have revised the frequency of home visits to assess the survival status to include the period of the study in the methods section under the subheading 'Vaccination data'. It now reads "The HDSS field teams visited all households 3-4 times a year during the period of the study from 1996 to 2012 document demographic events such as births, deaths and migrations".
Reviewer3
The trends are examined for change in neonatal mortality rate and age of BCG vaccination generally. However, the authors do not further examine this question by looking to see if the age at vaccination was associated with mortality. Rather, they lumped the infants into vaccinated and unvaccinated, and compared the neonatal mortality rates. This comparison does not address their question of earlier vaccination, rather vaccination in general.
Response
The reason for examining the changing trends in the median age of BCG vaccination and neonatal mortality rate at the population level was to show whether there was an association or correlation between the changing trends in BCG vaccination age and neonatal mortality over the period. The changing BCG vaccination age has to do with the time of receiving the vaccine. To further examine whether there was an association between the age at BCG vaccination and neonatal mortality at the individual level, we conducted the individual level analysis to assess the mortality difference between those vaccinated with BCG before 28 days and BCG-unvaccinated children.
Even though we did not clearly state what we referred to as early BCG vaccination in the individual level analysis, our approach implicitly refers to being vaccinated with BCG, at least, in the first 28 days after birth. Our approach produces results that can show that receiving BCG vaccine, at least, in the neonatal period may be associated with improve child survival during the neonatal period compared to the unvaccinated.
Reviewer3
As many interventions have changed in Northern Ghana, it would have been informative to look at changes in cause of death over this time period. Again, this would only be an association, but would provide further information if it was deaths due to TB, or that simply changing the system of care and having home visits was beneficial for early detection and treatment of illness, etc. As this is a hypothesis-generating paper, this would add value.
Response
During the period of this study, no neonatal death was recorded from TB. As indicated in the study setting, infections, birth injury and asphyxia and prematurity are the three leading causes of neonatal deaths in the area. We have added a supplementary 
Reviewer3
Unfortunately, I do not think the research question is able to be adequately answered in this manuscript. This is a very interesting question, however the evidence to provide more than parallel declines in both NMR and age at BCG vaccination is limited. It seems that the authors have great data on the community intervention, and the ability to statistically decrease the age of BCG vaccination. It seems that could be the focus of the re-write of this manuscript and a much more interesting and informative paper.
Response
Our study is primarily an ecological study with all its limitations in terms of the strength of the evidence and ecological fallacy that we acknowledged in our study. However, we believe that the findings are useful and could help to generate other hypotheses that more detailed epidemiological approaches can be used to investigate. It would be considered unethical to conduct randomized control trials (RCTs) in assessing the non-specific effects of BCG vaccines on child survival for all children since WHO is already recommending BCG from birth. RCTs among low-birth-weight children have shown strong beneficial effects of BCG on neonatal mortality (Biering-Sørensen et al., CID 2017). Our results are entirely consistent with the limited data from RCTs. Hence, the evidence from observational data, despite all the weaknesses, can be very useful in prompting policy makers and researchers to invest more in this area of research which has the potential to further improve child health using the already existing vaccines.
We are therefore attaching a revised version of the paper with track changes and one clean version. 
GENERAL COMMENTS
The objective in the abstract is "to assess the nonspecific effects of early BCG vaccination on neonatal mortality in Northern Ghana". The title is misleading by including the word "causality". It is impossible to determine causality in this type of research study. Even the word "linked" may be interpreted as causality. This study will only show an association, and the authors should be more careful to not overstate their findings.
There is a typo or missing information in the abstract, third sentence. neonatal mortality declined "with" 24/1000. The author could say declined from __ to __, or declined "by" __/1000 live births.
MethodsIt is unclear why infants delivered in health facilities and vaccinated would be excluded from this study. Also, in the methods, it becomes clear that the authors are looking at death between the interval from first home visit and 28 days. However, it is not defined the time period in which these home visits occur.
Unfortunately, I do not think the research question is able to be adequately answered in this manuscript. This is a very interesting question, however the evidence to provide more than parallel declines in both NMR and age at BCG vaccination is limited. It seems that the authors have great data on the community intervention, and the ability to statistically decrease the age of BCG vaccination. It seems that could be the focus of the re-write of this manuscript and a much more interesting and informative paper. PW: We didn't have cause of death data for this study. However, previous analysis of causes of neonatal deaths in the area showed that 32% of the causes were from infections, 21% from birth injury and asphyxia, and 18% from prematurity, making these three the leading causes of neonatal deaths in the area. This has been included in the manuscript on page 5.
VERSION 2 -AUTHOR RESPONSE
Reviewer 3:
In general, the description of the neonatal mortality rate and BCG vaccination rates and timing of vaccination was adequate. However, the methods for the statistical testing of an association of these two variables over time were incomplete. A test of this association in the overall cohort, in addition to the subgroup based on place of delivery would be worthwhile if this information is known.
Response:
This was largely an ecological study. 
Reviewer 3:
Response:
PW: Table 1 has been included that shows the demographic characteristics of mothers and neonates in the analysis. The details in the numbers presented in Tables 2 and 3 are to enable readers to easily calculate and know how the mortality rates were obtained.
Reviewer 3:
Response:
PW: The last two sentences in the second paragraph under the discussion section briefly discussed the role of the CHPS intervention in contributing to the decline in BCG vaccination age. We have now added the highlighted sentence. It reads "The Community-based Health Planning and Services (CHPS) program, which was tested in the study area, also contributed to the decline in age at BCG vaccination. Community health officers and community health nurses resident in the community were able to visit mothers at home to deliver vaccines. Getting the vaccination programme to function efficiently to ensure that BCG vaccines are administered early after birth could help reduce neonatal mortality."
We don't have any data or information on the education of the providers of home deliveries or data on a marker of illness severity at the time of birth. With regard to the vaccine being a cointervention within a bundle of care or counseling that accompanies the administration of the vaccine as well as possible differences in the groups vaccinated vs. unvaccinated, we have added the following paragraph indicating some of the limitations of the study as suggested.
"This was largely an ecological study, and ecological fallacy may be a major challenge in making causal inference on the individual level in this study. In the small observational study of individual level data, we were limited with respect to the number of confounders that we could adjust for due to lack of data. There are likely many unmeasured differences between the BCG vaccinated and unvaccinated children. For example, it is possible that BCG vaccinated children could have benefited from some form of care or counseling from health workers at the time of vaccination that this study could not document. We were also limited on the number of children included at the individual level analysis due to the strict inclusion criteria of first visiting the child in the first 28 days of life. The likely uncontrolled confounders and low statistical power could have affected our risk estimates."
Reviewer 3:
Response: PW: Culturally, mothers and their newborns in this study area are often kept away from the public and are most of the time indoors during the first month after delivery. We suspect fieldworkers who visit these households so early after delivery were most likely given convenient answers to prevent them from having access to the mother and the baby. We think this is most likely the reason for under-reporting of BCG vaccination in the first month of life. This contextual information has now been provided on page 13.
Is there any local data to suggest that stock-outs or availability of vaccine are an issue in facilities in this study? In the conclusion, the authors recommend that funders consider monitoring local implementation practices regarding wastage management. This is one important issue in implementation, however there may be others. An additional general sentence advising the construction of a process map or use of continuous quality improvement methodology at individual facilities may be advisable to learn about the barriers to timely implementation of BCG to all eligible infants.
Response:
PW: Even though we are aware that occasionally there could be stock-out of vaccines, this was not documented and unfortunately we don't have data on stock-out periods. We have added a sentence as part of our recommendations on page 13 advising individual health facilities to consider constructing a process map or make use of continuous quality improvement methodology to learn about the barriers to timely administration of BCG to all eligible infants. It reads "Individual health facilities may consider constructing a process map or use of continuous quality improvement methodology to learn about the barriers to timely administration of BCG to all eligible infants."
Response PW: We have revised our manuscript to address the issues raised by the reviewers.
Specific suggestions:
Reviewer 2:
We have revised our manuscript to include a paragraph that highlights some of the limitations pointed out by the reviewers. It reads "This was largely an ecological study, and ecological fallacy may be a major challenge in making causal inference on the individual level in this study. In the small observational study of individual level data, we were limited with respect to the number of confounders that we could adjust for due to lack of data. There are likely many unmeasured differences between the BCG vaccinated and unvaccinated children. For example, it is possible that BCG vaccinated children could have benefited from some form of care or counseling from health workers at the time of vaccination that this study could not document. We were also limited on the number of children included at the individual level analysis due to the strict inclusion criteria of first visiting the child in the first 28 days of life. The likely uncontrolled confounders and low statistical power could have affected our risk estimates."
Reviewer 2:
Response PW: We have also added a paragraph discussing the possibility of reverse causality as a possible explanation for our results. It reads "There has not been any recorded policy to delay or withhold BCG vaccination from severely ill young neonates in the period of this study in the study area. Even though we could not assess the degree to which BCG vaccination is delayed or withheld, it is possible that some health workers or mothers could decide to delay or withhold BCG vaccination due to severe illness, even though this is not an official policy. Therefore, the possibility of reverse causality as a possible partial explanation for the observed association between early BCG vaccination and neonatal mortality cannot be ruled out." However, the unvaccinated group should have become an increasingly select frail group as the vaccination coverage increased, and the mortality rate among unvaccinated children should therefore have increased over time. This did not happen (Supplementary Table 3) , and we therefore do not think that reverse causality is the predominant explanation.
Response PW: The statement "Nonetheless, the effect size was similar to that observed in two RCTs in Bissau, where BCG reduced neonatal mortality by 48%" has been revised to read as "Nonetheless, the effect size was similar to that observed in three RCTs in Bissau, where BCG vaccination was associated with a 38% reduction in neonatal mortality". These estimates have been updated since a third trial and a meta-analysis has just been published (see reference 7).
The discussion has also been expanded to include some of the steps that WHO is undertaking to adequately address the question on the beneficial effect of BCG on infant survival. It reads "To address the question on whether BCG has non-specific beneficial effects on infant survival, SAGE established a working group on non-specific effects of vaccines, including BCG. The WHO immunization and vaccines related implementation research advisory committee (IVIR-AC) concluded that RCTs were indeed required to resolve the question.
17
WHO recently circulated a call for public comments on draft protocols of clinical trials to assess any non-specific effects of BCG and measles vaccine. 20,21 However, we have discussed these design issues for future trials on different platforms as the issue here is not directly related to the topic of the paper. If the editors want, we can include some discussions on the topic. Response PW: The sentence "However, there are several reasons why the results suggest that the decline in mortality rates over the period is causally linked to the decline in BCG vaccination age" has been replaced with "However, there are several reasons why the results suggest that the decline in mortality rates over the period may be associated with the decline in BCG vaccination age"
Reviewers 2:
Response: PW: On other factors that might have accounted for the decline in neonatal mortality over the study period, we added the following paragraph: "There were other factors that might have accounted for the decline in neonatal mortality rates over the period. Some of these factors include improvement in the health care delivery system (availability of better obstetric care, better primary health care services), demographic changes (fewer number of children per household), general improvement in the economy of the area (improved income levels, infrastructure, maternal education, employment), improvement in the nutritional status of neonates, etc. "
Reviewer 2:
Response: PW: The sentence "Immunological studies have recently showed that BCG vaccines can train the innate immune system via epigenetic modifications at the monocyte level, and thus provided a mechanism whereby early BCG administration can modulate a child's ability to combat concurrent or subsequent unrelated infections" has been revised to read as "Immunological studies have recently shown that BCG vaccines can train the innate immune system via epigenetic modifications at the monocyte level.
8 This could possibly provide a mechanism whereby early BCG administration could modulate a child's ability to combat subsequent unrelated infections. "
Response: PW: We have added the following sentences explaining the landmark approach and how it reduces the tendency of survival bias on page 7." Survival bias leads to differential misclassification of vaccine status because children who survive have better information than those who died during follow-up because health cards for dead children were often not available for inspection. This leads to incomplete vaccine information for the dead children making vaccination to be automatically associated with a strong beneficial effect. In the landmark approach, only vaccine information collected on the date of visit is used, and the vaccine status becomes a time-fixed variable during follow-up in the analysis. This approach gives conservative estimates."
We have now indicated that we used a Cox regression model for the sub-group analysis on the last paragraph of page 6.
Reviewers 2:
Response: PW: Before we provide the details of the proportion, we would like to indicate that when a child is visited at the household, we find out whether the child has a health card and request to see it. There are four options given: 1-Yes seen, 2-Yes, but card not seen (missing), 3-No card, and 4-No information (not met or unavailable, migrated, etc.). Those who indicated 2-yes, but card not seen and those who indicated 4-No information or not met were excluded from the individual level analysis. Those classified as not been vaccinated were those who indicated that they didn't have or never had a card. Response: PW: In scenario 2 described by the reviewers, the landmark approach was used to avoid such misclassification of vaccination status as a result of some children not surviving, which will possibly lead to overestimation of the protective effect of the vaccine. We have added the following statement to indicate children with missing vaccination cards or those we did not meet at the time of visit were excluded from the analysis of the sub-study with individual level data on page 7. It reads "Children whose vaccination cards were not seen or those we did not meet at the time of visit were excluded from the sub-study analysis."
Reviewer 2:
Response: PW:We have provided more details in the methods section and indicated that there was no loss to follow-up in the study. There was no loss to follow-up in this study because of the short follow-up in neonatal period. The Health and Demographic Surveillance System (HDSS) team that monitors the survival status of these children had more frequent visits of 3-4 times in a year to households. We have added a statement in the methods section indicating that there was no loss to follow-up in this study.
PW:
In the individual level analysis, "the exposure data (vaccination status) were collected before the occurrence of the outcome for all participants. The criteria for inclusion was that a child should first be visited and be alive at the time of the visit in the first 28 days after birth. It was only in subsequent visits that an outcome could be assessed. The exposure data (vaccination) and the outcome data (survival) were independently collected, in most cases, by different fieldworkers." This has now been included in the methodological description of the individual level analysis on page 7.
Response: PW: Under normal circumstances, NMR among births without access to emergency obstetric care should be higher than those with some degree of access. However, NMR among births without access to emergency obstetric care could be similar to that among births with some degree of access due to more complicated delivery cases, usually with a higher risk of dying during the neonatal period, being sent to health facilities for delivery. This may offset the benefits of having access to emergency obstetric care.
Reviewer 2:
Response PW: We have described it as a sub-study with individual level data as suggested by the reviewers. There are several confounding factors that we wish we could adjust for in this analysis, but due to data limitations, we could not do so. As indicated in our previous response to one of the questions on limitations of our study, we have discussed some of the potential confounders and the limitations of getting data on these confounders in the discussion section. We have also increased the number of confounders we adjusted for by including season of birth and maternal age. Even though we were interested in exploring whether sex was an effect modifier, we were challenged with the limited data that we have in the sub-study with individual level data. For instance, among females, there was no death recorded for BCG-vaccinated girls. We assessed whether the HRs differ for boys and girls. For boys, the HR for BCG-vaccinated versus unvaccinated children was 0.92(0.20-4.25). For girls, the HR was zero due to no death among BCG-vaccinated girls, and the interaction was not statistically significant (P=1.00).
We have added in the results section on page 9 the following sentences "In the sub-study with individual level data, the HR for BCG-vaccinated boys versus BCG-unvaccinated boys was 0.92(0.20-4.25), and for girls, the HR was zero due to no death among the BCG-vaccinated girls; test of interaction (P=1.00)." Reviewer 2:
